ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,797Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 636

$1.07M Total Retail Price of All Prescriptions

Rank: 7 out of 636

975 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 975 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

13% of this provider’s 975 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 20,672 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LISINOPRIL 1,023 930 1 1
METOPROLOL TARTRATE 1,001 955 2 2
SIMVASTATIN 937 861 3 4
FUROSEMIDE 793 737 4 5
HYDROCHLOROTHIAZIDE 730 644 5 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 528 442 6 32
LEVOTHYROXINE SODIUM 520 490 7 30
OMEPRAZOLE 483 435 8 29
METFORMIN HCL 424 393 9 47
DIGOXIN 392 384 10 15
AMLODIPINE BESYLATE 378 344 11 7
WARFARIN SODIUM 351 335 12 8
LABETALOL HCL 322 302 13 68
CARVEDILOL 314 293 14 3
ALLOPURINOL 303 296 15 64
AZITHROMYCIN 263 226 16 70
LOSARTAN POTASSIUM 256 221 17 16
ATORVASTATIN CALCIUM 250 248 18 9
TRAMADOL HCL 250 210 18 57
PRAVASTATIN SODIUM 244 224 20 13
NIFEDIPINE ER 242 224 21 59
SPIRONOLACTONE-HCTZ 240 208 22 91
LOSARTAN-HYDROCHLOROTHIAZIDE 228 222 23 40
POTASSIUM CHLORIDE 206 194 24 19
ATENOLOL 201 179 25 14
NEXIUM 195 186 26 56
CLOPIDOGREL 191 178 27 10
SERTRALINE HCL 179 145 28 66
NIFEDICAL XL 175 149 29 90
KLOR-CON M20 173 160 30 33
BYSTOLIC 172 156 31 36
AMOXICILLIN 171 153 32 130
GLIMEPIRIDE 169 148 33 96
PLAVIX 164 128 34 12
MELOXICAM 155 144 35 85
DONEPEZIL HCL 153 153 36 84
METOPROLOL SUCCINATE 152 133 37 6
CLONIDINE HCL 144 131 38 43
GABAPENTIN 143 126 39 60
ATENOLOL-CHLORTHALIDONE 135 131 40 110
HYDROCODONE-ACETAMINOPHEN 134 127 S3 41 51
LORAZEPAM 132 117 42 120
ACETAMINOPHEN-CODEINE 131 111 S3 43 150
LEVOFLOXACIN 129 119 44 142
ENALAPRIL MALEATE 128 119 45 37
DICYCLOMINE HCL 126 121 46 169
ISOSORBIDE MONONITRATE ER 126 117 46 11
OXYCODONE-ACETAMINOPHEN 124 110 S2 48 77
VERAPAMIL ER 119 111 49 83
KLOR-CON M10 118 107 50 72
ALENDRONATE SODIUM 115 115 51 79
INSULIN SYRINGE 113 100 52 155
CELEBREX 113 105 52 156
CRESTOR 111 104 54 17
PREDNISONE 109 100 55 74
LYRICA 105 99 56 126
MECLIZINE HCL 102 94 57 189
ZOLPIDEM TARTRATE 102 86 57 69
SPIRONOLACTONE 100 99 59 20
GLYBURIDE 99 89 R 60 102
TAMSULOSIN HCL 95 94 61 96
DIOVAN 94 75 62 31
IBUPROFEN 92 77 63 135
PAROXETINE HCL 92 89 63 133
THEOPHYLLINE ANHYDROUS 89 86 65 192
CILOSTAZOL 88 82 66 63
GLIPIZIDE 87 85 67 124
AMIODARONE HCL 87 58 67 21
ROPINIROLE HCL 82 78 69 143
ESCITALOPRAM OXALATE 78 78 70 164
RISPERIDONE 77 71 71 113
SPIRIVA 76 74 72 116
CITALOPRAM HBR 76 75 72 86
NAMENDA 73 73 74 104
HYDROCODONE BIT-IBUPROFEN 73 64 S3 74 202
COMBIVENT 67 39 76 169
NITROSTAT 66 64 77 22
BENAZEPRIL-HYDROCHLOROTHIAZIDE 66 64 77 213
MEGESTROL ACETATE 66 62 R 77 168
TRIAMCINOLONE ACETONIDE 65 57 80 174
METHYLPREDNISOLONE 65 60 80 173
HUMULIN 70-30 64 62 82 216
DOXYCYCLINE HYCLATE 64 59 82 166
OXYBUTYNIN CHLORIDE 63 61 84 145
PANTOPRAZOLE SODIUM 62 62 85 53
HYDRALAZINE HCL 62 41 85 34
FAMOTIDINE 62 54 85 100
KLOR-CON 10 61 55 88 88
TRIAMTERENE-HCTZ 60 51 89 52
TEMAZEPAM 60 60 89 226
DIOVAN HCT 59 59 91 78
ISOSORBIDE DINITRATE 58 58 92 89
TERAZOSIN HCL 58 56 92 119
AMOX TR-POTASSIUM CLAVULANATE 58 50 92 228
NIFEDIAC CC 57 43 95 140
CIPROFLOXACIN HCL 57 53 95 93
DOXAZOSIN MESYLATE 56 50 97 62
DIPHENOXYLATE-ATROPINE 56 48 97 230
ADVAIR DISKUS 55 52 99 118
RANEXA 55 55 99 25
QUINAPRIL HCL 54 54 101 61
NOVOLOG MIX 70-30 54 54 101 235
MIRTAZAPINE 53 48 103 111
NAPROXEN 53 45 103 121
FENOFIBRATE 52 52 105 45
NOVOLIN 70-30 51 50 106 241
SINGULAIR 51 51 106 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.